Sunday 31 August 2014

Electrochemiluminescence immunoassay for progesterone by using a heterologous system in plasma bovine

11Electrochemiluminescence immunoassay for progesterone by using a heterologous system in plasma bovine - A. Ayad, M. Iguer Ouada and H. Benbarek
Veterinary World, 7(8): 610-613


   doi: 10.14202/vetworld.2014.610-613


A. Ayad: Department of Environment and Biological Sciences, Faculty of Life and Nature Sciences, University A. Mira, 06000, Bejaia, Algeria; Laboratory of Research on Local Animal Products, Veterinary Institute, Ibn Khaldoun University, 14000, Tiaret, Algeria; hanine06@gmail.com,abdelhanine.ayad@univ-bejaia.dz
M. Iguer Ouada: Department of Environment and Biological Sciences, Faculty of Life and Nature Sciences, University A. Mira, 06000,
Bejaia, Algeria; imokrane@gmail.com
H. Benbarek: Laboratory of Research on Local Animal Products, Veterinary Institute, Ibn Khaldoun University, 14000, Tiaret, Algeria; Department of Agricultural Sciences, Faculty of Life and Nature Sciences, University M. Istambouli, 29000, Mascara, Algeria; benbarekh@yahoo.com

Received: 12-05-2014, Revised: 27-07-2014, Accepted: 02-08-2014, Published online: 21-08-2014

Corresponding author: A. Ayad, email: hanine06@gmail.com, abdelhanine.ayad@univ-bejaia.dz


Aim: The present study describes the use of electrochemiluminescence (ECL) immunoassay method with specific kit human progesterone for measuring plasma progesterone in cattle.
Materials and Methods: Nine Holstein-Friesian females were selected and artificially inseminated (AI). Blood samples were collected from the coccygeal vessels into tubes containing EDTA at day 0 (n = 5, the control group) and day 90 (n = 4, diagnosed pregnant by rectal palpation) after AI. The day of AI was considered as day 0 for the calculation of pregnancy day. The samples were immediately centrifuged (15 min at 1500 × g), and the plasma was stored at 20°C until assay. The assay of progesterone was carried out by a method of competition immunological type in heterogeneous phase. The antibodies of capture and revelation are monoclonal specific to progesterone of human origin.
Results: The progesterone (P4) concentration in the whole female was physiological. The results of inter- and intraassay coefficients of variation were 16.6% and 6.7%, respectively. The values of accuracy and parallelism obtained were satisfactory.
Conclusion: The preliminary results show clearly that human progesterone ECL kit can be used to measure P4 in plasma bovine.

Keywords: assay, cow, electochemiluminescence, progesterone.

Saturday 30 August 2014

Benefit cost analysis of Rhode Island Red chicken rearing in backyard on the basis of egg production performance

10. Benefit cost analysis of Rhode Island Red chicken rearing in backyard on the basis of egg production performance - P. K. Das, P. R. Ghosh, S. Pradhan, B. Roy and D. Mazumdar
Veterinary World, 7(8): 605-609


   doi: 10.14202/vetworld.2014.605-609


P. K. Das: Department of Veterinary Physiology, West Bengal University of Animal & Fishery Sciences, 37, K. B. Sarani, Kolkata - 700 037, West Bengal, India; pkdaskol@rediffmail.com
P. R. Ghosh: Department of Veterinary Physiology, West Bengal University of Animal & Fishery Sciences, 37, K. B. Sarani, Kolkata - 700 037, West Bengal, India; drprghosh@gmail.com
S. Pradhan: Department of Veterinary Pathology, West Bengal University of Animal & Fishery Sciences, 37, K. B. Sarani, Kolkata - 700 037, West Bengal, India; saktipadapradhan@gmail.com
B. Roy: Department of Animal Nutrition, West Bengal University of Animal & Fishery Sciences, 37, K. B. Sarani, Kolkata - 700 037, West Bengal, India; barunnutrition@yahoo.co.in
D. Mazumdar: Department of Agriculture Statistics, Bidhan Chandra Krishi Viswavidyalaya, West Bengal, India; debstat@gmail.com

Received: 29-04-2014, Revised: 01-07-2014, Accepted: 07-07-2014, Published online: 16-08-2014

Corresponding author: P. K. Das, email: pkdaskol@rediffmail.com



Thursday 28 August 2014

Multistate Outbreak of Human Salmonella Infections Linked to Live Poultry in Backyard Flocks

Source: http://www.cdc.gov/salmonella/live-poultry-05-14/index.html


Highlights


A retrospective study on incidence of lameness in domestic animals

Research (Published online: 15-08-2014)
9. A retrospective study on incidence of lameness in domestic animals - A. Mohsina, M. M. S Zama, P. Tamilmahan, M.B.Gugjoo, K. Singh, A. Gopinathan, M. Gopi and K.Karthik
Veterinary World, 7(8): 601-604


   doi: 10.14202/vetworld.2014.601-604


A. Mohsina: Division of Veterinary Surgery, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;sowparnika777@gmail.com
M. M. S Zama: Division of Veterinary Surgery, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;mmszama@yahoo.com
P. Tamilmahan: Division of Veterinary Surgery, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;drtamilmahan.bison@gmail.com
M. B. Gugjoo: Division of Veterinary Surgery, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;mbgugjoo@gmail.com
K. Singh: Division of Veterinary Surgery, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;ksuppli@yahoo.co.in
A. Gopinathan: Division of Veterinary Surgery, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;aswathykiran77@gmail.com
M. Gopi: Division of Animal Nutrition, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;gopsgopi72@gmail.com
K. Karthik: Division of Bacteriology, Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India;karthik_2bvsc@yahoo.co.in

Received: 23-04-2014, Revised: 28-06-2014, Accepted: 05-07-2014, Published online: 15-08-2014

Corresponding author: A. Mohsina, email: sowparnika777@gmail.com, Cell: +91-9458587867



Molecular detection of Toxoplasma gondii DNA in milk and risk factors analysis of seroprevalence in pregnant women at Sharkia, Egypt

8. Molecular detection of Toxoplasma gondii DNA in milk and risk factors analysis of seroprevalence in pregnant women at Sharkia, Egypt -Heba A. Ahmed, Saleh M. Shafik, Mahmoud E. M. Ali, Sanya T. Elghamry and Alshymaa A. Ahmed
Veterinary World, 7(8): 594-600


   doi: 10.14202/vetworld.2014.594-600

 
Heba A. Ahmed: Department of Zoonoses, Faculty of Veterinary Medicine, Zagazig University, 44511, Zagazig, Egypt; heba_ahmed@zu.edu.eg
Saleh M. Shafik: Food Hygiene Department, Animal Health Research Institute, Mansoura, Egypt; Saleh_Shafik@yahoo.com
Mahmoud E. M. Ali: Food Hygiene Department, Animal Health Research Institute, Mansoura, Egypt; dr_hashem59@yahoo.com
Sanya T. Elghamry: Food Hygiene Department, Animal Health Research Institute, Mansoura, Egypt; sanyaelghamry@yahoo.com
Alshymaa A. Ahmed: Clinical pathology Department, Faculty of Medicine, Zagazig University, Egypt; doaa_ahmed57@yahoo.com

Received: 10-05-2014, Revised: 26-06-2014, Accepted: 03-07-2014, Published online: 12-08-2014

Corresponding author: Heba A. Ahmed, email: heba_ahmed@zu.edu.eg



Detection of Mycobacterium avium subsp. paratuberculosis from cattle and buffaloes in Egypt using traditional culture, serological and molecular based methods

7. Detection of Mycobacterium avium subsp. paratuberculosis from cattle and buffaloes in Egypt using traditional culture, serological and molecular based methods - G. S. Abdellrazeq, M. M. El-Naggar, S. A. Khaliel and A. E. Gamal-Eldin
Veterinary World, 7(8): 586-593


   doi: 10.14202/vetworld.2014.586-593

 
G. S. Abdellrazeq: Department of Microbiology, Faculty of Veterinary Medicine, Alexandria University, Edfina, Rosetta-line, P. O. Box: 22758, Egypt;gaber.abdellatif@alexu.edu.eg
M. M. El-Naggar: Department of Microbiology, Faculty of Veterinary Medicine, Alexandria University, Edfina, Rosetta-line, P. O. Box: 22758, Egypt; mahmoud.elnaggar@alexu.edu.eg
S. A. Khaliel: Department of Microbiology, Faculty of Veterinary Medicine, Alexandria University, Edfina, Rosetta-line, P. O. Box: 22758, Egypt;khaliel1@yahoo.com
A. E. Gamal-Eldin: Department of Microbiology, Faculty of Veterinary Medicine, Alexandria University, Edfina, Rosetta-line, P. O. Box: 22758, Egypt;dr_asmaa9518@yahoo.com

Received: 03-05-2014, Revised: 02-07-2014, Accepted: 10-07-2014, Published online: 11-08-2014

Corresponding author: Gaber Abdellrazeq, email: gaber.abdellatif@alexu.edu.eg



Three-quarters of depressed cancer patients do not receive treatment for depression; new approach could transform care

Three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology reveal that around three-quarters of cancer patients who have major depression are not currently receiving treatment for depression, and that a new integrated treatment program is strikingly more effective at reducing depression and improving quality of life than current care.
An analysis of data from more than 21,000 patients attending cancer clinics in Scotland, UK, published inThe Lancet Psychiatry, found that major depression is substantially more common in cancer patients than in the general population. Major depression was most common in patients with lung cancer (13%) and lowest in those with genitourinary cancer (6%). Moreover, nearly three quarters (73%) of depressed cancer patients were not receiving treatment.
To address the problem of inadequate treatment the SMaRT Oncology-2 randomised trial, published inThe Lancet, evaluated the effectiveness of a new treatment program called 'Depression Care for People with Cancer' (DCPC). DCPC is delivered by a team of specially trained cancer nurses and psychiatrists, working in collaboration with the patient's cancer team and general practitioner, and is given as part of cancer care. It is a systematic treatment program that includes both antidepressants and psychological therapy.
The trial, involving 500 adults with major depression and a cancer with a good prognosis (predicted survival more than 12 months) compared DCPC with usual care [1]. DCPC was strikingly more effective at reducing depression. At 6 months, 62% of the patients who received DCPC responded to treatment (at least a 50% reduction in the severity of their depression) compared with only 17% of those who received usual care. This benefit was sustained at 12 months. DCPC also improved anxiety, pain, fatigue, functioning, and overall quality of life. Moreover, the cost of providing DCPC was modest (£613 per patient) making it a cost-effective way to improve cancer patients' quality of life.
According to lead author Professor Michael Sharpe from the University of Oxford in the UK, "The huge benefit that DCPC delivers for patients with cancer and depression shows what we can achieve for patients if we take as much care with the treatment of their depression as we do with the treatment of their cancer."
To see if patients with a poor prognosis cancer could also benefit from this approach, the SMaRT Oncology-3 randomised trial, published in The Lancet Oncology, tested a version of DCPC adapted for patients with a typically poor prognosis cancer (lung cancer). The trial, involving 142 patients with lung cancer and major depression, found that those who received the lung cancer version of DCPC had a significantly greater improvement in depression than those who received usual care during 32 weeks of follow-up. The lung cancer-specific version of DCPC also improved anxiety, functioning, and quality of life.
According to study leader Dr Jane Walker from the University of Oxford and Sobell House Hospice in Oxford in the UK, "Patients with lung cancer often have a poor prognosis. If they also have major depression that can blight the time they have left to live. This trial shows that we can effectively treat depression in patients with poor prognosis cancers like lung cancer and really improve patients' lives."

Story Source:
The above story is based on materials provided by The LancetNote: Materials may be edited for content and length.

Journal References:
  1. Michael Sharpe et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical dataThe Lancet Psychiatry, August 2014 DOI:10.1016/S2215-0366(14)70313-X
  2. Michael Sharpe, Jane Walker, Christian Holm Hansen, Paul Martin, Stefan Symeonides, Charlie Gourley, Lucy Wall, David Weller, Gordon Murray. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.The Lancet, 2014; DOI: 10.1016/S0140-6736(14)61231-9
  3. Jane Walker, Christian Holm Hansen, Paul Martin, Stefan Symeonides, Charlie Gourley, Lucy Wall, David Weller, Gordon Murray, Michael Sharpe. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancerThe Lancet Oncology, 2014; DOI: 10.1016/S1470-2045(14)70343-2

Cite This Page:
The Lancet. "Three-quarters of depressed cancer patients do not receive treatment for depression; new approach could transform care." ScienceDaily. ScienceDaily, 27 August 2014. <www.sciencedaily.com/releases/2014/08/140827203635.htm>.